Biohaven Ltd. (BHVN) Financials
BHVN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 382.7 million | 92.7 million |
2023-06-30 | 506.7 million | 119.5 million |
2023-03-31 | 618.5 million | 146.3 million |
2022-12-31 | 661.8 million | 123.0 million |
BHVN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -96.1 million | 4.5 million |
2023-06-30 | -45.0 million | 4.7 million |
2023-03-31 | -78.4 million | 3.8 million |
2022-12-31 | -75.7 million | 115.6 million |
BHVN Net Income
No data available :(
BHVN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 240.6 million | - | 31.6 million |
2023-06-30 | 335.1 million | - | 29.1 million |
2023-03-31 | 388.0 million | - | 29.8 million |
2022-12-31 | 465.3 million | - | 30.6 million |
BHVN Shares Outstanding
BHVN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 1.2 million | 95.5 million | 15.0 million | - |
2023-06-30 | 595000 | 79.5 million | 14.5 million | - |
2023-03-31 | 735000 | 63.5 million | 14.3 million | - |
2022-12-31 | 300000 | 137.0 million | 76.4 million | - |
BHVN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 857000 |
2023-06-30 | - | 800000 |
2023-03-31 | - | 764000 |
2022-12-31 | -215.1 million | 35.7 million |
BHVN
Price: $40.69
52 week price:
Earnings Per Share: -5.73 USD
P/E Ratio: -6.15
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Volume: 704100
Ebitda: -42.6 millionMarket Capitalization: 4.3 billion